Sarah Cannon Research Institute
Whitley Fleenor BS, MPH, currently serves as a Study Coordinator at Sarah Cannon since October 2021, leading the execution of clinical trials, managing patient eligibility, and ensuring compliance with study protocols. Previously, Whitley held the position of Data Coordinator in Study Operations, specializing in late-phase Multiple Myeloma and Bone Marrow Transplant trials while managing over 15 trials. Whitley's prior experience includes roles in patient registration, public health internships, and as an Activity Director, showcasing a strong background in healthcare management, patient care, and community health. Whitley earned a Master’s Degree in Public Health from Mercer University and a Bachelor of Science in Biology from Columbus State University.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.